The invention relates to humanized 6F4 homogeneous antibodies, a target of which is antigen JAM-A, that are capable of inhibiting tumor cells proliferation. There are also provided: complete amino acid sequences of districts (CDR) defining heavy and light chains complementarities, pharmaceutical composition containing the same and their application at various types of cancer treatment.